Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy
Authors:
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 128 (1) , 227-232
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (1037746)
- University of Sydney
- Magnetic Health Science Foundation
This publication has 28 references indexed in Scilit:
- Contrasting echogenicity in flexor digitorum profundus–flexor carpi ulnaris: A diagnostic ultrasound pattern in sporadic inclusion body myositisMuscle & Nerve, 2013
- Validity and reliability of nerve and muscle ultrasoundMuscle & Nerve, 2013
- Anterior tibialis cmap amplitude correlations with impairment in CMT1AMuscle & Nerve, 2012
- Reliability of the CMT neuropathy score (second version) in Charcot‐Marie‐Tooth diseaseJournal of the Peripheral Nervous System, 2011
- Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialThe Lancet Neurology, 2011
- Muscle changes in amyotrophic lateral sclerosis: A longitudinal ultrasonography studyClinical Neurophysiology, 2011
- Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosisMuscle & Nerve, 2011
- Assessing spinal muscular atrophy with quantitative ultrasoundNeurology, 2010
- The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up studyBrain, 2009
- Skeletal Muscle Ultrasound: Correlation Between Fibrous Tissue and Echo IntensityUltrasound in Medicine & Biology, 2009